COMMUNIQUÉS West-GlobeNewswire

-
Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium
27/01/2025 -
Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer
27/01/2025 -
Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer
27/01/2025 -
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter
27/01/2025 -
iCAD Pre-Announces Estimated Q4 2024 Revenue
27/01/2025 -
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
27/01/2025 -
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
27/01/2025 -
Dentzz Dental Reports Serving Over 100,000 Patients Worldwide, Highlighting Dental Tourism Trends
25/01/2025 -
Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure
24/01/2025 -
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/01/2025 -
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
24/01/2025 -
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/01/2025 -
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
24/01/2025 -
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
24/01/2025 -
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares following Loan Conversions
24/01/2025 -
AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET
24/01/2025 -
AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025, de 17h30 à 18h45
24/01/2025 -
Elevar Therapeutics Presents Results from Post-Hoc Analysis of CARES-310 Study Evaluating the Impact of Viral and Non-Viral Etiology on Survival in Hepatocellular Carcinoma
24/01/2025 -
Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia
24/01/2025
Pages